1 / 8

New Revenue Pockets for the Biomarkers Market

Biomarker Market for Diagnostic Applications is expected to garner $30.6 Billion Globally by 2020, registering a CAGR of 16% during the forecast period 2013 to 2020.<br>

srushtih123
Télécharger la présentation

New Revenue Pockets for the Biomarkers Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Biomarkers Market Global Opportunity Analysis and Industry Forecast, 2013-2020

  2. Biomarker Market Diagnostic biomarkers continue to address challenges such as early and accurate diagnosis of most of the fatal diseases. Increasing advancements with extended applications of diagnostic biomarkers are only going to increase its significance in the field of diagnostics 

  3. Biomarker Market Overview BiomarkersMarket Report, published by Allied Market Research, forecasts that the market is expected to garner $30.6 billion by 2020, registering a CAGR of 16% during the period 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.  Access Full Report at: https://www.alliedmarketresearch.com/biomarkers-market Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic add the analysts.Diagnostic biomarker market is growing with development of technologies in clinical laboratory tests, imaging exams, and in recent years biomarker tests are impacting the clinical management of patients. Biomarkers are identified conventionally by analyzing the science of pathophysiology and epidemiology, which derive insensitive and nonspecific markers.

  4. Biomarker Market Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. The biomarker market in this report includes the application of biomarkers in the diagnosis (molecular diagnosis and disease diagnosis), drug validation, drug development, risk assessment, drug formulation and forensic applications. Technologies that immensely make use of biomarkers such as Omics, imaging technologies, bioinformatics and personalized medicines are also included in the study. 

  5. Biomarker Market,Snapshot According to data published by ministry of health in China, about 203 million people are suffering from cardiovascular diseases and this number is expected to increase by 73% in 2030. Projected trends in blood pressure, increased cholesterol and active smoking are also increase the number of CVD by an additional 23% which denotes 21.3 million cardiovascular events. Demographic changes such as aging population and lesser younger people is the main driver for increased CVD disease. Biomarker market is expected to increase its presence as biopharmaceutical companies are investing more in Asian countries for drug discovery and development since market for health care process is more in Asia Pacific region. Application of biomarkers in drug discovery and development process, personalized medicine, molecular diagnosis, and diagnosis of other diseases are increases the interest of research based pharmaceutical company to develop novel biomarkers.

  6. Biomarkers Market Key Benefits • The report offers an assessment and ranking of the factors that favor the biomarkers market growth and those factors which act as a hindrance for the growth of the market • Forecast period for estimating market size is from 2013 to 2020. Two historic years include 2011 and 2012 • The report identifies top investment pockets and offers an analysis of top winning strategies for diagnostic biomarker industry. • The report analyses the various strategies adopted by some of the key companies in the industry. • The report tracks and analyses key innovations and patents for biomarkers in the last five years

  7. Biomarkers Market By Geography North America Europe Asia-Pacific LAMEA

  8. Biomarkers Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/biomarkers-market Follow Us On

More Related